Reflecting on a Career in Healthcare Collections, HFMA, and the Future of Healthcare Debt Recovery

Collections in general, but especially in the healthcare industry, require delicacy, patience, and intelligence, all while ensuring the company meets revenue goals and the client’s customer experience is cared for. IC System’s specially trained collections experts make this possible, from engaging in industry boards such as the Healthcare Financial Management Association (HFMA) and employing innovative tools as allowed by significant regulation.

On the newest episode of Closing the Books, a podcast by IC System, IC System’s  Bart Shea, VP of Client Development shares his personal journey in the industry, his passion for the HFMA, and his industry insights with host Gabrielle Bejarano.

The two discuss…

  • What Shea’s journey in the collections industry looked like
  • What the HFMA is and how to get involved
  • Where Shea see debt recovery going in 2023 and beyond

“It’s near and dear to my heart with making sure that our industry is up to speed on the changes in healthcare, whether that be from a compliance standpoint or just an actionable standpoint…but I think that the HFMA is truly one of the good vehicles that us as service providers…can actually have really good conversations with prospects that attend HFMA shows,” said Shea.

Shea has been with IC System for over two years as the VP of Client Development. He holds over two decades of experience in healthcare receivables management and previously spent time as the VP of Client Development – West for MedAssist and the National Director of Client Development for RevSolve, Inc. He is a HFMA Certified Revenue Cycle Representative (CRCR) and current President of the HFMA Arizona Chapter.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…